Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT)
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
Experiments suggest that low molecular weight heparin (LMWH) inhibits tumor growth and
metastasis. Studies in humans suggest that LMWH is associated with a higher survival in
patients with cancer related thrombosis. Two recent studies suggest that LMWH may increase
the survival of patients with cancer who do not have an associated thrombosis. The purpose of
the study is to assess the effect of LMWH on the overall survival of patients with localized
non-small cell lung cancer after complete surgical resection.